MILIP
gene geneOn this page
Summary
MILIP (MYC inducible lncRNA inactivating p53, HGNC:43649) is a long non-coding RNA gene on chromosome 17q25.3.
At a glance
- Gene type: non-coding (lncRNA) — no protein product.
- GTEx eGene: eQTL in 17 tissues, sQTL in 0 (q < 0.05)
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:43649 |
| Approved symbol | MILIP |
| Name | MYC inducible lncRNA inactivating p53 |
| Location | 17q25.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000265688 |
| Ensembl biotype | lncRNA |
| OMIM | 621176 |
| Entrez | 92659 |
| RNAcentral | URS000075B20D — lncRNA, 1914 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 lncRNA
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 1
ENST00000582106
RefSeq mRNA: 0
Canonical transcript exons
ENST00000582106 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002690534 | 81929476 | 81930753 |
| ENSE00002713444 | 81927829 | 81928445 |
Expression profiles
Bgee: expression breadth ubiquitous, 156 present calls, max score 79.53.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.8218 / max 54.1666, expressed in 1394 samples.
Highest expression (Bgee): primordial germ cell in gonad, secondary oocyte, male germ line stem cell (sensu Vertebrata) in testis, oocyte, stromal cell of endometrium.
Genetic regulation across tissues (GTEx eQTL / sQTL)
MILIP is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 17 tissues and its splicing (sQTL) in 0 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
17 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Spleen | eqtl | 8.9e-12 | +2.26 | 17:81927264:G:A |
| Brain Substantia nigra | eqtl | 8.4e-11 | -0.63 | 17:81951661:G:A |
| Cells Cultured fibroblasts | eqtl | 2.8e-07 | +0.63 | 17:81927853:C:A |
| Cells EBV-transformed lymphocytes | eqtl | 2.4e-05 | +1.49 | 17:81927853:C:A |
| Artery Aorta | eqtl | 1.0e-04 | +0.78 | 17:81927853:C:A |
| Brain Cerebellar Hemisphere | eqtl | 2.6e-04 | -0.22 | 17:81943789:T:G |
| Nerve Tibial | eqtl | 3.6e-04 | +0.64 | 17:81927264:G:A |
| Muscle Skeletal | eqtl | 1.1e-03 | +0.62 | 17:81927853:C:A |
| Adrenal Gland | eqtl | 1.3e-03 | +0.98 | 17:81927853:C:A |
| Heart Left Ventricle | eqtl | 1.4e-03 | +1.15 | 17:81927264:G:A |
| Adipose Subcutaneous | eqtl | 1.9e-03 | +0.74 | 17:81936383:A:G |
| Prostate | eqtl | 8.0e-03 | -1.10 | 17:82049082:T:C |
| Artery Tibial | eqtl | 1.3e-02 | +0.63 | 17:81927853:C:A |
| Brain Hypothalamus | eqtl | 2.4e-02 | -0.25 | 17:81946986:G:GTAATAA |
| Brain Cerebellum | eqtl | 4.0e-02 | -0.19 | 17:81961589:A:C |
| Whole Blood | eqtl | 4.2e-02 | +0.79 | 17:81936383:A:G |
| Brain Putamen basal ganglia | eqtl | 4.9e-02 | -0.62 | 17:81436179:C:T |
FANTOM5 promoters
2 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 163383 | 2.3109 | 1158 |
| 208458 | 1.5108 | 866 |
Top tissues by expression
showing 100 of 230 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.53 | gold quality |
| secondary oocyte | CL:0000655 | 78.77 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.92 | gold quality |
| oocyte | CL:0000023 | 74.84 | silver quality |
| stromal cell of endometrium | CL:0002255 | 74.62 | gold quality |
| cortical plate | UBERON:0005343 | 72.73 | gold quality |
| adenohypophysis | UBERON:0002196 | 72.48 | gold quality |
| ventricular zone | UBERON:0003053 | 72.27 | gold quality |
| parotid gland | UBERON:0001831 | 71.96 | gold quality |
| buccal mucosa cell | CL:0002336 | 71.68 | gold quality |
| pituitary gland | UBERON:0000007 | 71.51 | gold quality |
| right testis | UBERON:0004534 | 70.12 | gold quality |
| left testis | UBERON:0004533 | 70.07 | gold quality |
| right uterine tube | UBERON:0001302 | 68.77 | gold quality |
| testis | UBERON:0000473 | 68.63 | gold quality |
| ganglionic eminence | UBERON:0004023 | 66.56 | gold quality |
| bronchial epithelial cell | CL:0002328 | 65.89 | silver quality |
| bronchus | UBERON:0002185 | 65.38 | silver quality |
| lower esophagus mucosa | UBERON:0035834 | 64.83 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 64.19 | gold quality |
| nucleus accumbens | UBERON:0001882 | 63.90 | gold quality |
| esophagus mucosa | UBERON:0002469 | 63.75 | gold quality |
| prefrontal cortex | UBERON:0000451 | 63.69 | gold quality |
| cartilage tissue | UBERON:0002418 | 63.68 | gold quality |
| left uterine tube | UBERON:0001303 | 63.45 | gold quality |
| body of pancreas | UBERON:0001150 | 62.57 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 62.55 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 62.48 | gold quality |
| caudate nucleus | UBERON:0001873 | 62.44 | gold quality |
| ectocervix | UBERON:0012249 | 62.44 | gold quality |
| neocortex | UBERON:0001950 | 62.40 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 62.34 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 62.27 | gold quality |
| forebrain | UBERON:0001890 | 62.21 | gold quality |
| frontal cortex | UBERON:0001870 | 62.18 | gold quality |
| islet of Langerhans | UBERON:0000006 | 62.01 | gold quality |
| putamen | UBERON:0001874 | 61.91 | gold quality |
| pancreas | UBERON:0001264 | 61.81 | gold quality |
| mammary duct | UBERON:0001765 | 61.80 | gold quality |
| uterine cervix | UBERON:0000002 | 61.77 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 61.71 | gold quality |
| right frontal lobe | UBERON:0002810 | 61.65 | gold quality |
| cortex of kidney | UBERON:0001225 | 61.62 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 61.57 | gold quality |
| brain | UBERON:0000955 | 61.52 | gold quality |
| myocardium | UBERON:0002349 | 61.45 | gold quality |
| cerebral cortex | UBERON:0000956 | 61.27 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 61.22 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 61.20 | gold quality |
| endocervix | UBERON:0000458 | 61.10 | gold quality |
| body of uterus | UBERON:0009853 | 61.02 | gold quality |
| hypothalamus | UBERON:0001898 | 60.98 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 60.97 | gold quality |
| esophagus | UBERON:0001043 | 60.81 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 60.78 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 60.72 | gold quality |
| amygdala | UBERON:0001876 | 60.61 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 60.12 | gold quality |
| minor salivary gland | UBERON:0001830 | 60.10 | gold quality |
| temporal lobe | UBERON:0001871 | 60.02 | gold quality |
| fallopian tube | UBERON:0003889 | 59.97 | gold quality |
| seminal vesicle | UBERON:0000998 | 59.91 | silver quality |
| thyroid gland | UBERON:0002046 | 59.86 | gold quality |
| myometrium | UBERON:0001296 | 59.73 | gold quality |
| apex of heart | UBERON:0002098 | 59.63 | gold quality |
| metanephros cortex | UBERON:0010533 | 59.42 | gold quality |
| mouth mucosa | UBERON:0003729 | 59.21 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 59.09 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 58.95 | gold quality |
| Ammon’s horn | UBERON:0001954 | 58.89 | gold quality |
| metanephros | UBERON:0000081 | 58.85 | gold quality |
| substantia nigra | UBERON:0002038 | 58.76 | gold quality |
| cerebellum | UBERON:0002037 | 58.73 | gold quality |
| primary visual cortex | UBERON:0002436 | 58.72 | gold quality |
| cerebellar cortex | UBERON:0002129 | 58.68 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 58.64 | gold quality |
| upper lobe of lung | UBERON:0008948 | 58.55 | gold quality |
| ascending aorta | UBERON:0001496 | 58.52 | gold quality |
| skin of abdomen | UBERON:0001416 | 58.33 | gold quality |
| thoracic aorta | UBERON:0001515 | 58.30 | gold quality |
| gall bladder | UBERON:0002110 | 58.23 | gold quality |
| midbrain | UBERON:0001891 | 58.15 | gold quality |
| kidney | UBERON:0002113 | 58.11 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 58.07 | gold quality |
| skin of leg | UBERON:0001511 | 57.97 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 57.97 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 57.95 | gold quality |
| left adrenal gland | UBERON:0001234 | 57.95 | gold quality |
| occipital lobe | UBERON:0002021 | 57.82 | gold quality |
| lower esophagus | UBERON:0013473 | 57.68 | gold quality |
| right ovary | UBERON:0002118 | 57.66 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 57.62 | gold quality |
| prostate gland | UBERON:0002367 | 57.43 | gold quality |
| adrenal cortex | UBERON:0001235 | 57.37 | gold quality |
| vagina | UBERON:0000996 | 57.36 | gold quality |
| zone of skin | UBERON:0000014 | 57.30 | gold quality |
| body of stomach | UBERON:0001161 | 57.29 | gold quality |
| anatomical system | UBERON:0000467 | 57.02 | gold quality |
| cerebellar vermis | UBERON:0004720 | 56.99 | gold quality |
| upper leg skin | UBERON:0004262 | 56.90 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.98 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 16)
- suggested that MAFG-AS1 functions as a novel oncogenic lncRNA in the development of CRC by regulating miR-147b/NDUFA4 (PMID:30348529)
- LncRNA MAFG-AS1 promotes the aggressiveness of breast carcinoma through regulating miR-339-5p/MMP15. (PMID:31002134)
- LncRNA MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via regulating miR-744-5p/MAFG axis (PMID:31211984)
- MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer. (PMID:32079456)
- Long noncoding RNA MAFG-AS1 facilitates the progression of hepatocellular carcinoma via targeting miR-3196/OTX1 axis. (PMID:33336731)
- Regulatory effect of the MAFGAS1/miR1505p/MYB axis on the proliferation and migration of breast cancer cells. (PMID:33367930)
- LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells. (PMID:33400245)
- LncRNA MAFG-AS1 affects the tumorigenesis of breast cancer cells via the miR-574-5p/SOD2 axis. (PMID:33989902)
- LncRNA MAFG-AS1 promotes the malignant phenotype of ovarian cancer by upregulating NFKB1-dependent IGF1. (PMID:34035482)
- LncRNA MAFG-AS1 deregulated in breast cancer affects autophagy and progression of breast cancer by interacting with miR-3612 and FKBP4 invitro. (PMID:35653827)
- LncRNA MILIP links YBX1 to translational activation of Snai1 and promotes metastasis in clear cell renal cell carcinoma. (PMID:36028903)
- LncRNA MAFG-AS1-induced acute myeloid leukemia development via modulating miR-147b/HOXA9. (PMID:36229729)
- The N-Myc-responsive lncRNA MILIP promotes DNA double-strand break repair through non-homologous end joining. (PMID:36445966)
- MAFG-AS1/MAFG positive feedback loop contributes to cisplatin resistance in bladder urothelial carcinoma through antagonistic ferroptosis. (PMID:36654385)
- A review on the roles and molecular mechanisms of MAFG-AS1 in oncogenesis. (PMID:36736142)
- Long non-coding RNA MAFG-AS1: A promising therapeutic target for human cancers. (PMID:37105079)
Cross-species orthologs
0 orthologs
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| MAFG-AS1 | ncRNA | 128385369 |
| NPB | protein-coding | 256933 |
| MAFG | protein-coding | 4097 |
| SIRT7 | protein-coding | 51547 |
| PYCR1 | protein-coding | 5831 |
| PCYT2 | protein-coding | 5833 |
| ALYREF | protein-coding | 10189 |
| ANAPC11 | protein-coding | 51529 |
| MYADML2 | protein-coding | 255275 |
| NOTUM | protein-coding | 147111 |
Protein
Non-coding RNA — no protein product.
Function
Gene-set membership (MSigDB)
This non-coding RNA is a member of 26 curated MSigDB gene sets — regulatory-target and signature collections that include it (it has no protein-based pathway / GO / interaction data).
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP, LIAO_METASTASIS, E2F3_UP.V1_UP, MAFG_TARGET_GENES, NCOA6_TARGET_GENES, RBM34_TARGET_GENES, TFEB_TARGET_GENES, ZBTB12_TARGET_GENES, ZFP91_TARGET_GENES, ZNF354B_TARGET_GENES, ZNF410_TARGET_GENES, ZNF423_TARGET_GENES, ZNF507_TARGET_GENES, ZNF561_TARGET_GENES, ZNF830_TARGET_GENES, ZSCAN30_TARGET_GENES, BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN, AHRR_TARGET_GENES, MZF1_TARGET_GENES, ZNF549_TARGET_GENES, MYOCD_TARGET_GENES, TRAVAGLINI_LUNG_PROXIMAL_CILIATED_CELL, CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP, GSE2706_R848_VS_LPS_2H_STIM_DC_DN, chr17q25, GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN
ncRNA interactions
Experimentally supported non-coding-RNA interaction partners (NPInter).
showing 4 of 50 interaction partners:
| Partner | Partner type | Level | Source |
|---|---|---|---|
| MAFG-AS1 | lncRNA | RNA-Protein | High-throughput data |
| MAFG-DT | lncRNA | RNA-Protein | High-throughput data |
| miR-125b-5p | miRNA | RNA-RNA | Literature mining |
| miR-143-3p | miRNA | RNA-RNA | Literature mining |
Disease & clinical
ncRNA disease associations
Curated non-coding-RNA → disease associations (LncRNADisease, HMDD) — these are RNA-level associations for this gene, not the positional variant data omitted above.
showing 19 of 27 ncRNA–disease associations:
| Disease | Causal? | Validated by |
|---|---|---|
| Carcinoma, Hepatocellular | No | qRT-PCR |
| Ovarian Neoplasms | Yes | Transwell Assay, Wound Healing Assay, qRT-PCR, FISH, RIP, Colony Formation Assay, ChIP |
| Carcinoma, Hepatocellular | Yes | Western Blot, CCK8, qRT-PCR, RIP, Luciferase Report Assay, Transwell Assay |
| Esophageal Squamous Cell Carcinoma | Yes | RNA Pull-Down, Western Blot, qRT-PCR, Luciferase Report Assay, Transwell Assay |
| Prostatic Neoplasms | Yes | Invasion Assay, Migration Assay, qRT-PCR, RNA-seq, Cell Proliferation Assay, Colony Formation Assay, Bioinformatics Analysis, Transwell Assay |
| Carcinoma, Non-Small-Cell Lung | Yes | qRT-PCR |
| Breast Neoplasms | Yes | RNA Pull-Down, CCK8, qRT-PCR, RIP, Luciferase Report Assay, BrdU, ELISA |
| Leukemia, Myeloid, Acute | Yes | qRT-PCR, Luciferase Report Assay |
| Urinary Bladder Neoplasms | Yes | qRT-PCR, Wound Healing Assay |
| Colorectal Neoplasms | Yes | Western Blot, qRT-PCR, MTT, Luciferase Report Assay, Transwell Assay |
| Glioblastoma | Yes | Western Blot, Wound Healing Assay, CCK8, qRT-PCR, Flow Cytometry, Colony Formation Assay |
| Breast Neoplasms | No | CCK8, qRT-PCR, Invasion Assay, Migration Assay |
| gastric adenocarcinoma | Yes | CCK8, qRT-PCR, Luciferase Report Assay, Western Blot |
| bladder urothelial carcinoma | Yes | IHC, Western Blot, Wound Healing Assay, Co-IP, qRT-PCR, FISH, RIP, MTT, IP, Colony Formation Assay, Transwell Assay |
| Carcinoma, Renal Cell | Yes | In Vivo Experiment, RNA Pull-Down, Western Blot, Wound Healing Assay, Migration Assay, qRT-PCR, RIP, Invasion Assay, Transwell Assay |
| Stomach Neoplasms | Yes | qRT-PCR |
| Adenocarcinoma of Lung | Yes | CCK8, FISH, EdU Staining, Western Blot |
| Colorectal Neoplasms | No | qRT-PCR |
| Urinary Bladder Neoplasms | No | qRT-PCR, Luciferase Report Assay, RIP |
Drugs & pharmacology
ncRNA–drug associations
Curated non-coding-RNA → drug associations (drug response / resistance / target).
showing 5 of 7 ncRNA–drug associations:
| Drug | Relation | Effect | Condition |
|---|---|---|---|
| Oxaliplatin | drug_resistance | sensitive | cell line (MHCC97H) |
| Gemcitabine | drug_resistance | resistant | “cell line (HuCCT1, SNU-245)” |
| Tamoxifen | drug_resistance | resistant | “cell line (MCF-7, BT-474, T47D, MCF-10A)” |
| Oxaliplatin | drug_target | down-regulated | cell line (MHCC97H) |
| Panobinostat | drug_target | down-regulated | “cell line (SK-NEP-1, G401)” |
Related Atlas pages
- Associated diseases (ncRNA): esophageal squamous cell carcinoma, urinary bladder neoplasm, glioblastoma, gastric adenocarcinoma, bladder transitional cell carcinoma, lung adenocarcinoma
- Associated drugs (ncRNA: response / resistance): Oxaliplatin, Gemcitabine, Tamoxifen, Panobinostat